These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16247070)
1. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Skipper L; Shen H; Chua E; Bonnard C; Kolatkar P; Tan LC; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yuen Y; Farrer M; Liu JJ; Tan EK Neurology; 2005 Oct; 65(8):1319-21. PubMed ID: 16247070 [TBL] [Abstract][Full Text] [Related]
2. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901 [TBL] [Abstract][Full Text] [Related]
3. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8. Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834 [TBL] [Abstract][Full Text] [Related]
4. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822 [TBL] [Abstract][Full Text] [Related]
5. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population. Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation. Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782 [TBL] [Abstract][Full Text] [Related]
8. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369 [TBL] [Abstract][Full Text] [Related]
9. LRRK2: both a cause and a risk factor for Parkinson disease? Foroud T Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895 [No Abstract] [Full Text] [Related]
10. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants. Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462 [TBL] [Abstract][Full Text] [Related]